Fort Worth, TX

Fort Worth, Texas 76104

0 studies enrolling now · 3 studies all time

What they study most

COVID-19, Diabetic Macular Edema (DME)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) — Stopped early